Blockchain Registration Transaction Record

Phlow Corp Secures $37M in Series C Funding to Combat Drug Shortages

Phlow Corp closes $37M Series C funding led by Align Private Capital to combat U.S. drug shortages and enhance pharmaceutical supply chain resilience.

This news is crucial as it highlights Phlow Corp's efforts to address and mitigate the chronic shortages of essential medicines in the U.S., including those for pediatric care. By securing significant funding and forming strategic partnerships, Phlow is enhancing the resilience of the pharmaceutical supply chain, ensuring the availability of critical medications for Americans, especially in times of health crises. Their work not only supports the general public but also aids the U.S. military and its allies in preparing for chemical and biological threats, showcasing a comprehensive approach to national healthcare security.